![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.405 | -10.51% | 3.45 | 3.01 | 3.89 | 3.89 | 3.88 | 3.89 | 200,973 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -8.41M | -0.0418 | -0.93 | 7.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/5/2020 15:59 | You holding stock here judi? | ![]() soultrading | |
26/5/2020 15:56 | Not really astonishing Constant selling holding this back imho | ![]() judijudi | |
26/5/2020 15:51 | It is astonishing that we are languishing down here will the level of known info out there compared to other Covid-19 stocks. I am sure we will see a run up towards a £1 as we get close to these results being released | ![]() tburns | |
26/5/2020 15:38 | All the papers covering the story now | ![]() soultrading | |
26/5/2020 15:29 | I did wonder the same thing China dog, but to the south of Southampton also happens to be The Isle of Wight, which is where the Codid19 track and trace app is being trialled. Potentially you could see Track, Trace and Treat all working in harmony.. Also, there is a large retired population on the Isle of Wight so that may also be a consideration.Primar | the real capitalcity | |
26/5/2020 15:24 | Good interview. Clearly a lot of effort has been put into organising the Home trial. He was unsure on end date depending on level of infection in the community - hoping for late Summer. It does sound ambitious, my dad is in his 80s and lives alone, he has trouble answering his landline phone, not much chance of him managing a zoom consultation. He doesn't have a PC or smartphone. | ![]() pdt | |
26/5/2020 14:39 | Someone mentioned on LSE that Synairgen’s involvement may prejudice it’s independence. Dunno what people think? | ![]() wetdream | |
26/5/2020 14:37 | https://www.proactiv | slinkyj | |
26/5/2020 14:33 | I was more concerned about recruitment and the ongoing PRINCIPLE trial ( quite different but via primary care). However, I think the sample size of 120 isnt overly ambitious and locality loyalties are on their side. SNG are also sorting the CV swab testing and have full control which is a big benefit too. | ![]() 141jaffa | |
26/5/2020 14:23 | I already checked that concern.....a third of that area is indeed water ! However, it seems the rest has a population of circa 3.13m ! | ![]() 141jaffa | |
26/5/2020 14:20 | Possibly logistics. If the patient is stuck or has difficulty it would be easier to respond timely and involve a minimal team. If the patients illness escalates they can monitor and review /compare at Southampton general with any potential other persons that may need to be admitted. There is quite a large population in 40 miles, southampton, portsmouth, Bournemouth, Basingstoke etc . It makes sense to me as some will be on placebo and a quick logistics action needs to be performed if someone goes downhill on that. | slinkyj | |
26/5/2020 14:08 | Why restrict the home trial to 40 mile radius. To the South is sea so smaller still! | chinadog3 | |
26/5/2020 13:58 | To be fair, a cursory scan of the six month chart would suggest to your average investor/punter that SNG has had its ‘COVID’ moment in reaching 50/60p, so a pause is expected. Those longer-termers (ie. next 2 months....) will need patience. | ![]() wetdream | |
26/5/2020 13:54 | The MM's will take 45k for 50.85p. That tells me they want the shares!! | ![]() vitec | |
26/5/2020 13:53 | I’ve read the RNS 3 times now. Share price to a degree takes in future potential. This just isn’t happening here. Off the back of that RNS we should be flying. Oh well. One day ! | ![]() peachie 74 | |
26/5/2020 13:47 | Can sell just under ask... | itshenderz | |
26/5/2020 13:46 | Buys flying in. No doubt being soaked up by a big bloody sell order that will show later. AIM really does test your nerve | ![]() peachie 74 | |
26/5/2020 13:43 | L2 looks poised to tick up... | itshenderz | |
26/5/2020 13:39 | Well the spread is just .02p (bought some at 50.8 but can sell multiples of this at 50.65) A balanced book and the seller done (for today?) I also wonder if they might open up any further trial centres? One in the USA would be excellent on a number of fronts. | ![]() waterloo01 | |
26/5/2020 13:35 | Nobby what’s your take regarding the COPD early release of data. Does this mean they plan to unbind and release results with just the 109? | s120896 | |
26/5/2020 13:29 | Royalalbert > Thats because DDDD have almost exactly the same issue (drug for Covid-19 treatment in development trials). I hold SNG, DDDD and AVCT for info. (and TEK too). | ![]() ambyth | |
26/5/2020 13:17 | Ambyth stick with AVCT, you have posted same piece on DDDD board. | ![]() royalalbert |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions